Peculiarities of the Reproductive Health of Women Affected by Hepatobiliary Disorders
Oleksandra Boychuk1 and Nsan Ekom Nsed Ebaye2*
1Professor at the Subdepartment of Obstetrics and Gynecology of the Department of Postgraduate Studies of Ivano-Frankivsk National Medical University, Ukraine
2Bakor Medical Center, Cross River State, Calabar, Director of Clinical Services, Nigeria
*Corresponding Author: Nsan Ekom Nsed Ebaye, Bakor Medical Center, Cross River State, Calabar, Director of Clinical Services, Nigeria.
November 01, 2021; Published: November 30, 2021
The World Health Organization considers the protection of reproductive health to be a priority area of its activities and calls on all countries to ensure further development of programs promoting reproductive health .
In 2006, the UN General Assembly adopted are commendation to include the goal of achieving general access to reproductive healthcare in the Five Millennium Development Goals. Environment, working conditions, social aspects of people’s life, mental condition, somatic disorders – all these factors influence the functional condition of the reproductive system.
Keywords: Peculiarities; Reproductive Health; WHO
- WHO Reproductive Health Strategy (2004).
- Yuzko ОМ., et al. “Assisted reproductive technologies in Ukraine: pregnancy, labor, newborns”. Women’s Doctor 4 (2013): 52-53.
- Ovsiannikova TV., et al. “Contemporary principles of diagnosis and treatment of infertility”. Gynecology 4 (2009): 30-33.
- Yuzko ОМ., et al. “Assisted reproductive technologiesin Ukraine”. Women’s Doctor 3 (2007): 8.
- VI Kulakov., et al. “Structure of female infertility and prognosis of recovery of the reproductive function at the use of the contemporary endoscopic methods”. Obstetrics and Gynecology 3 (2001): 33-36.
- Mishiyeva NG. “Infertility in women of advanced maternal age: principles of diagnosis and treatment depending on the ovarian r: abstract of MD dissertation”. Moscow (2008): 47.
- Quality clinical treatment with the use of assisted reproductive technologies. ESHRE program document. Access mode (2008).
- Skrypnyk ІМ. “Clinical hepatology”. Poltava: Dyvosvit (2007): 425.
- Podymova SD. “Liver diseases”. 4th edition, revised. Мoscow: Meditsyna (2005): 704.
- Karachentsev АN. “Hepatobiliary system as target for adverse effects of medicinal estrogens and gestagens”. Russian Bulletin of Obstetrics and Gynecology 6 (2004): 20-25.
- RA Wilke., et al. “Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges”. Nature Reviews Drug Discovery 11 (2007): 904 -916.
- Upadhyay RD., et al. “Proteomics in reproductive biology: beacon for unravelling the molecular complexities”. Biochimica et Biophysica Acta1 (2013): 8-15.
- Dubossarskaya YА. “Hepatobiliary pathology in gynecological practice”. Medical Aspects of Women’s Health30 (2010): 12-19.
- TS Della., et al. “AminoAcid-Dependent Activation of Liver Estrogen Receptor Alpha Integrated Metabolic and Reproductive Functions via IGF”. Cell Metabolism2 (2011): 205-214.
- PM Gowri., et al. “Lipin1 Regulation by Estrogen in Uterus and Liver: Implications for Diabetes and Fertility”. Endocrinology87 (2007): 3685-3693.
- Bełtowski J “Liver X receptor (LXR) and the reproductive system - a potential novel target for therapeutic intervention”. Pharmacological Reports1 (2010): 15-27.
- Ignatova ТМ. “Liver diseases in pregnant women”. Medical Bulletin of the North Caucasus 2 (2009): 88-93.
- Bacq Y. “Liver diseases unique to pregnancy: a 2010 update”. Clinics and Research in Hepatology and Gastroenterology 35 (2011): 182-193.
- ОІ Fediv., et al. “Peculiarities of etiology and pathogenesis of intrahepatic cholestasis of pregnancy”. Clinical and Experimental Pathology1 (2013): 197-200.
- Kramarev SА “Contemporary hepatoprotective drugs in hepatology”. Pediatrician 1 (2011): 5-9.